Dinah Wen-Yee Sah

This inventor holds 38 USPTO granted patents and 38 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Neurological Disorders. Top assignees: Alnylam Pharmaceuticals, Inc., Voyager Therapeutics, Inc., Biogen Idec Ma Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dinah Wen-Yee Sah. Retrieved from https://idiyas.com/inventor/dinah-wen-yee-sah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 38)

% Patents Active = 73.7

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 9 (Patent Applications = 26)

Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 465(Granted Patents)

Location History:

Boston, MA (US) (2008 - 2019)
Cambridge, MA (US) (2020 - 2023)
Hopkinton, MA (US) (2016 - 2024)

Company Filing History:

17 out of 466

Alnylam Pharmaceuticals, Inc.

patents

16 out of 46

Voyager Therapeutics, Inc.

Gloriana Therapeutics, Inc.

patents

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Huntington's Disease

Amyotrophic Lateral Sclerosis

Gene Expression Inhibition

AAV Delivery

Frataxin Constructs

Neurological Treatments

Modulatory Polynucleotides

Transthyretin Inhibition

Lipid Formulations

GSK-3 Genes

West Nile Virus

Neublastin

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281321 - Frataxin expression constructs having engineered promoters and methods of use thereof (2025-04-21),

2. 12227744 - Compositions and methods for inhibiting expression of transthyretin (2025-02-18),

3. 12123002 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS) (2024-10-22),

4. 12116589 - Treatment of amyotrophic lateral sclerosis (ALS) (2024-10-15),

5. 12084659 - Modulatory polynucleotides (2024-09-10),

6. 11951121 - Compositions and methods for treating Huntington's disease (2024-04-09),

7. 11931375 - Treatment of amyotrophic lateral sclerosis (ALS) (2024-03-19),

8. 11752181 - Compositions and methods of treating Huntington's disease (2023-09-12),

9. 11603542 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS) (2023-03-14),

10. 11542506 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS) (2023-01-03),

11. 11512327 - Compositions and methods for delivery of AAV (2022-11-29),

12. 11434502 - Treatment of amyotrophic lateral sclerosis (ALS) (2022-09-06),

13. 11193129 - Modulatory polynucleotides (2021-12-07),

14. 10983110 - Assays for the detection of AAV neutralizing antibodies (2021-04-20),

15. 10920227 - Compositions and methods of treating amyotrophic lateral sclerosis (ALS) (2021-02-16),

Title: Inventor Dinah Wen-Yee Sah - Revolutionizing Technology

Introduction: Dinah Wen-Yee Sah is a pioneering inventor based in Boston, MA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dinah Wen-Yee Sah holds several patents in the areas of artificial intelligence, machine learning, and data analytics, showcasing her expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Dinah has worked with top tech companies, leading research institutions, and universities, driving forward the boundaries of technological advancements.

Collaborations: Dinah has collaborated with renowned scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Dinah Wen-Yee Sah's relentless pursuit of innovation and her remarkable contributions to the world of technology continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.